Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment

In the previous paper of ours we compared, prior to start any treatment, a number of immunological parameters in 24 chronic myeloid leukemia patients with the same number of healthy subjects matched by age and sex. We found significant differences in the levels of immunoglobulins, the C4 component o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zuzana Humlová, Hana Klamová, Ivana Janatková, Karin Malícková, Petra Králíková, Ivan Šterzl, Zdeněk Roth, Eva Hamšíková, Vladimír Vonka
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2010/137320
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555131800911872
author Zuzana Humlová
Hana Klamová
Ivana Janatková
Karin Malícková
Petra Králíková
Ivan Šterzl
Zdeněk Roth
Eva Hamšíková
Vladimír Vonka
author_facet Zuzana Humlová
Hana Klamová
Ivana Janatková
Karin Malícková
Petra Králíková
Ivan Šterzl
Zdeněk Roth
Eva Hamšíková
Vladimír Vonka
author_sort Zuzana Humlová
collection DOAJ
description In the previous paper of ours we compared, prior to start any treatment, a number of immunological parameters in 24 chronic myeloid leukemia patients with the same number of healthy subjects matched by age and sex. We found significant differences in the levels of immunoglobulins, the C4 component of complement, the C-reactive protein, interleukin 6, the composition of lymphocyte population and the production of some cytokines by stimulated CD3+ cells. Eleven of these patients were followed longitudinally. After treatment with hydroxyurea, interferon alpha, imatinib mesylate and dasatinib, or various combinations thereof, hematological remission was achieved in all patients and complete cytogenetic remission in nine of them. There was a nearly general tendency towards normalization of the abnormalities observed in the patients at their enrollment.
format Article
id doaj-art-c618fc624da74bea9a63dc767bf29762
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-c618fc624da74bea9a63dc767bf297622025-02-03T05:49:37ZengWileyClinical and Developmental Immunology1740-25221740-25302010-01-01201010.1155/2010/137320137320Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of TreatmentZuzana Humlová0Hana Klamová1Ivana Janatková2Karin Malícková3Petra Králíková4Ivan Šterzl5Zdeněk Roth6Eva Hamšíková7Vladimír Vonka8Department of Immunology and Microbiology, 1st Medical Faculty, Charles University, and the General Teaching Hospital in Prague, Karlovo náměstí 32, 121 11 Prague 2, Czech RepublicClinical Department, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech RepublicDepartment of Clinical Biochemistry and Laboratory Medicine, 1st Medical Faculty, Charles University, Karlovo náměstí 32, 121 11 Prague 2, Czech RepublicDepartment of Clinical Biochemistry and Laboratory Medicine, 1st Medical Faculty, Charles University, Karlovo náměstí 32, 121 11 Prague 2, Czech RepublicDepartment of Immunology, 2nd Medical Faculty, Charles University, V Úvalu 84, 150 06 Prague 5, Czech RepublicDepartment of Immunology and Microbiology, 1st Medical Faculty, Charles University, and the General Teaching Hospital in Prague, Karlovo náměstí 32, 121 11 Prague 2, Czech RepublicDepartment of Biostatistics, National Institute of Health, Šrobárova 48, 100 00 Prague 10, Czech RepublicDepartment of Experimental Virology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech RepublicDepartment of Experimental Virology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech RepublicIn the previous paper of ours we compared, prior to start any treatment, a number of immunological parameters in 24 chronic myeloid leukemia patients with the same number of healthy subjects matched by age and sex. We found significant differences in the levels of immunoglobulins, the C4 component of complement, the C-reactive protein, interleukin 6, the composition of lymphocyte population and the production of some cytokines by stimulated CD3+ cells. Eleven of these patients were followed longitudinally. After treatment with hydroxyurea, interferon alpha, imatinib mesylate and dasatinib, or various combinations thereof, hematological remission was achieved in all patients and complete cytogenetic remission in nine of them. There was a nearly general tendency towards normalization of the abnormalities observed in the patients at their enrollment.http://dx.doi.org/10.1155/2010/137320
spellingShingle Zuzana Humlová
Hana Klamová
Ivana Janatková
Karin Malícková
Petra Králíková
Ivan Šterzl
Zdeněk Roth
Eva Hamšíková
Vladimír Vonka
Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
Clinical and Developmental Immunology
title Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
title_full Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
title_fullStr Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
title_full_unstemmed Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
title_short Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
title_sort changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment
url http://dx.doi.org/10.1155/2010/137320
work_keys_str_mv AT zuzanahumlova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT hanaklamova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT ivanajanatkova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT karinmalickova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT petrakralikova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT ivansterzl changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT zdenekroth changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT evahamsikova changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment
AT vladimirvonka changesofimmunologicalprofilesinpatientswithchronicmyeloidleukemiainthecourseoftreatment